CTAD: Lecanemab On Track to File for FDA Approval In Early 2023
Much anticipated Phase 3 data for Alzheimer’s drug lecanemab was presented at CTAD in 2022, showing the drug is as safe as the placebo…
Much anticipated Phase 3 data for Alzheimer’s drug lecanemab was presented at CTAD in 2022, showing the drug is as safe as the placebo…
They’ve been studying the same group of people for 76 years. This is what they’ve learned about Alzheimer’s disease… so far. Psychology in epidemiology…
Does diet soda have a dementia link? Despite the occasional media frenzy over whether Diet Coke causes Alzheimer’s, here’s what the existing, credible, published…
The majority of Alzheimer’s research to date has been conducted in white participants. For example, the first FDA-approved anti-amyloid drug to treat Alzheimer’s, Aduhelm,…
Even though Alzheimer’s may start 20 years before symptoms first appear, there are no non-invasive diagnostics to detect it. An initiative called the Diagnostics…
Until a few decades ago, most scientific research and clinical drug trials were done in men. That means that, even though certain differences between…
In the midst of a media frenzy around fraud allegations and a key Alzheimer’s drug target, reporter Phil Gutis reflects on his personal experience…
A study found that closely following the MIND diet for brain health appeared to cut peoples’ Alzheimer’s risk in half. The diet’s creator discusses…
By 2050, it is estimated that 153 million people worldwide — more than one in every 100 — will be living with Alzheimer’s. While the…
As we age, we experience an increased risk of developing high blood pressure or hypertension — the leading risk factor for disease in the world. Dementia…
Ka`imi A. Sinclair has devoted her career to brain health equity in indigenous communities and to getting these communities more involved in Alzheimer’s and…
A new study predicts dementia cases will rise three-fold. Developing countries are expected to be the hardest hit. Eastern sub-Saharan Africa, North Africa and…
As part of an online conference hosted by the Alzheimer’s Foundation of America, Associate Professor of Medicine at New York University’s (NYU) Long Island…
A study finds that people who struggle to hear over background noise had as much as a 91-percent higher risk of dementia. Thomas Littlejohns,…
Alzheimer’s is a complex disease, and studies that follow participants over extended periods of time can gather troves of data on the progression of…